CD71+ erythroid cells as a potential early biomarker for hemodynamic significant patent ductus arteriosus in preterm infants
These results suggest that early measurement of CEC levels can identify preterm infants at high risk for hsPDA prior to echocardiographic diagnosis. As a potential predictive biomarker, CECs may improve risk stratification and guide timely intervention, ultimately enhancing clinical outcomes. Further research is needed to elucidate the mechanisms linking CECs to hsPDA.
Authors
- Jin-Hee Oh (ORCID: https://orcid.org/0000-0002-2893-0563)
- Jeongmin Shin (ORCID: https://orcid.org/0000-0002-0356-4747)
- JoungOk Kim
- Eun-Jee Oh
- Young-Ah Youn
- Min Soo Kim
- Jae Young Lee
- Ju Ae Shin
Institutions
- St. Mary's Hospital (US)
- The Catholic University of Korea St. Vincent's Hospital (KR)
- The Catholic University of Korea Seoul St. Mary's Hospital (KR)
- Catholic University of Korea (KR)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-01-13
- DOI
- https://doi.org/10.3389/fimmu.2025.1738166
- Citations
- 1
- Primary Topic
- Cardiovascular Conditions and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 31.92
Funders
- Catholic University of Korea
- Seoul St. Mary's Hospital, Catholic University of Korea